What is the structure of Glycomics Market and who are the key players?
Glycobiology Industry Overview:
The growth of this market is mainly driven by the key factors driving the growth of the glycomics market: increasing R&D spending and funding for proteomics and glycomics research, growth of the proteomics market and technological advancements in glycomics devices.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Increased government and organizational investment has enabled academic researchers to develop new glycomics and glycobiology tools. This factor is expected to drive the sugar science segment, driving the overall market. Glycoproteomics require advanced analytical methods to study pathogens and human glycobiology in disease and health.
The glycomics market, by enzymes, has been categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market.
By application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the glycomics market.
North America is the largest regional market for glycomics products
North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising R&D expenditure for drug discovery & development, and the presence of all key players.
Some prominent players in the global western blotting market Include:
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).
Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
Expected Revenue:
The global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% from 2020 to 2025.
Glycomics Market Segmentation
MarketsandMarkets has segmented the Glycomics Market based on Product Type, application, and region:
Product
- Enzymes
- Glycosidases & Neuramidases
- Glycosyltransferases & Sialytransferases
- Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
- Kits
- Glycan Releasing Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
- Carbohydrates
- Oligosaccharides
- Monosaccharides
- Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
- Reagents & Chemicals
Application
- Drug Discovery & Development
- Disease Diagnostics
- Other Applications (virology, cell biology, and microbiology)
End-user
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Latin America
- Middle East & Africa
Comments
Post a Comment